Acute Antiplatelet Effects of an Oleocanthal-Rich Olive Oil in Type II Diabetic Patients: A Postprandial Study.
Maria Efthymia KatsaKleopatra KetselidiMarianna KalliostraAnastasios IoannidisAndrea Paola Rojas GilPanagiotis DiamantakosEleni MelliouProkopios MagiatisTzortzis NomikosPublished in: International journal of molecular sciences (2024)
Postprandial dysmetabolism is a common entity of type 2 diabetes mellitus (T2DM) and may act as a daily stressor of the already dysfunctional diabetic platelets. This study aims to investigate whether oleocanthal-rich olive oils (OO), incorporated into a carbohydrate-rich meal, can affect postprandial dysmetabolism and platelet aggregation. Oleocanthal is a cyclooxygenase inhibitor with putative antiplatelet properties. In this randomized, single-blinded, crossover study, ten T2DM patients consumed five isocaloric meals containing 120 g white bread combined with: (i) 39 g butter, (ii) 39 g butter and 400 mg ibuprofen, (iii) 40 mL OO (phenolic content < 10 mg/Kg), (iv) 40 mL OO with 250 mg/Kg oleocanthal and (v) 40 mL OO with 500 mg/Kg oleocanthal. Metabolic markers along with ex vivo ADP- and thrombin receptor-activating peptide (TRAP)-induced platelet aggregation were measured before and for 4 h after the meals. The glycemic and lipidemic response was similar between meals. However, a sustained (90-240 min) dose-dependent reduction in platelets' sensitivity to both ADP (50-100%) and TRAP (20-50%) was observed after the oleocanthal meals in comparison to OO or butter meals. The antiplatelet effect of the OO containing 500 mg/Kg oleocanthal was comparable to that of the ibuprofen meal. In conclusion, the consumption of meals containing oleocanthal-rich OO can reduce platelet activity during the postprandial period, irrespective of postprandial hyperglycemia and lipidemia.
Keyphrases
- blood glucose
- type diabetes
- ejection fraction
- end stage renal disease
- glycemic control
- double blind
- liver failure
- newly diagnosed
- physical activity
- signaling pathway
- open label
- placebo controlled
- blood pressure
- diabetic rats
- intensive care unit
- metabolic syndrome
- prognostic factors
- high glucose
- patient reported outcomes
- oxidative stress
- postoperative pain
- acute respiratory distress syndrome
- nitric oxide synthase
- clinical evaluation